<DOC>
	<DOCNO>NCT00553488</DOCNO>
	<brief_summary>This study determine effect intra-dermal ( ID ) administration regular rapid-acting insulin , eat , blood glucose level several hour standard meal ( mixed , liquid meal ) . Insulin also give normally , subcutaneously , control comparison purpose . The hypothesis expectation ID insulin work quickly control blood glucose level well SC injection .</brief_summary>
	<brief_title>Feasibility Study Effect Intra-Dermal Insulin Injection Blood Glucose Levels After Eating</brief_title>
	<detailed_description>Previous study show intra-dermal ( ID ) insulin administration result rapid onset action comparison subcutaneous ( SC ) administration measure glucose infusion rate ( GIR ) glucose clamp conditions.The aim study investigate whether ID administration regular human insulin rapid-acting insulin analogue lead reduce postprandial glycemic excursion comparison SC application highly standardized experimental condition . Effects occurrence hypoglycemia also investigate , well pK pD comparison different insulin formulation administer ID . This mono-center , open-label , randomize , 5-period crossover study patient type 1 diabetes</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Type 1 diabetes 115 year , multiple daily injection ( MDI ) insulin pump ( CSII ) stable control HbA1c &lt; = 9.0 % . Able attend clinic 5 different day BMI &gt; 32 kg/m2 Evidence gastroparesis impair renal function lipodystrophy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>diabetes</keyword>
	<keyword>insulin</keyword>
	<keyword>subcutaneous</keyword>
	<keyword>intra-dermal</keyword>
	<keyword>blood glucose</keyword>
</DOC>